HLA-Class II Alleles in Egyptian Patients with Hepatocellular Carcinoma

REFERENCES

• Abdel-Wahab M., Abou El-Enein A., Abou-Zeid M., et al. Hepatocelular carcinoma in Mansoura-Egypt: experience of 385 patients at a single center. J. Hepatol. Gastroenterol. 2000; 47: 663–668
   Google Scholar
• Acton R.T. The major histocompatibility complex. Clinical Immunology Principles and Practice 2nd, R.R. Rich, T.A. Fleisher, W.T. Shearer, et al. Mosby International Ltd, London 2001; 1: 1–13
   Google Scholar
• Aikawa T., Kojimam M., Onishi H., et al. HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C. J. Med. Virol. 1996; 49(4)274–278
   PubMed Web of Science ®Google Scholar
• Alric L., Fort M., Izopet J., et al. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology 1997; 113: 675–1681, 1997
   PubMed Web of Science ®Google Scholar
• Alric L., Fort M., Izopet J., et al. Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance. Tissue Antigens 2000; 56: 154–158
   PubMedGoogle Scholar
• Chang K.M., Rehermann B., Chisari F.V. Immunopathology of hepatitis C. Springer Series, Seminar on Immunopathology 1997; 19: 57
   PubMed Web of Science ®Google Scholar
• Cramp M., Carucci P., Underhill J., et al. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J. Hepatol. 1998; 29: 207–213
   PubMed Web of Science ®Google Scholar
• De Re V., Caggiari L., Talamini R., et al. Hepatitis C virus-related hepato- cellular carcinoma and B-cell lymphoma patients show a different profile of major histocompatibility complex class II alleles. Human Immunol. 2004; 65: 1397–1404
   PubMed Web of Science ®Google Scholar
• Donaldson P.T. The interrelationship between hepatitis C virus and HLA. Eur. J. Clin. Invest. 1999; 29: 280–283
   PubMed Web of Science ®Google Scholar
• Donaldson P.T., Ho S., Williams R., et al. HLA class II alleles in Chinese patients with hepatocellular carcinoma. Liver 2001; 21: 143–148
   PubMedGoogle Scholar
• El-Borai M.H., D'alfonso S., Mazzola M.E., et al. A practical approach to HLA-DR genomic typing by heteroduplex analysis. Human Immunol. 1994; 40: 41–50
   PubMed Web of Science ®Google Scholar
• El-Shinnawi F.A., Djoulah S., Abbas F., et al. HLA class II DRB1 and DQB1 polymorphisms in the Egyptian population of Siwa. Human Immunol. 1996; 47: 142
   Web of Science ®Google Scholar
• El-Zayadi A., Abaza H., Shawky S., et al. Prevalence and epidemiological features of hepatocellular carcinoma in Egypt—a Single center experience. Hepatol. Res. 2001; 19(2)170–179
   PubMed Web of Science ®Google Scholar
• El-Zayadi A., Simmonds P., Dabbous H., et al. Response to interferone-α of Egyptian patients infected with hepatitis C virus genotype 4. J. Viral Hepatitis 1996; 3: 261–264
   PubMed Web of Science ®Google Scholar
• Fanning L.J., Levis J., Kenny-Walsh E., et al. HLA class II genes determine the natural variance of hepatitis C viral load. Hepatology 2001; 33: 224–230
   PubMed Web of Science ®Google Scholar
• Hafez M., El-Shinnawi F.A. HLA-antigens in the Egyptian population. Foren. Sci. Inter. 1986; 31: 241–246
   PubMed Web of Science ®Google Scholar
• Hamed N.A., Hano A.F., Raouf H.A., et al. Relationship between HLA-DR B1*0101, DRB1*0301 alleles and interleukin-12 in haemophilic patients and hepatitis C virus positive hepatocellular carcinoma patients. Int. J. Cancer 2005; 115(2)231–240
   PubMedGoogle Scholar
• Herkel J., Jagemann B., Wiegard C., et al. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocytes. Hepatology 2003; 37: 1079
   PubMed Web of Science ®Google Scholar
• Higashi Y., Kamikawaji N., Suko H., Ando M. Analysis of HLA alleles in Japanese patients with cirrhosis due to chronic hepatitis C. J. Gastroenterol. Hepatol. 1996; 11: 241–246
   PubMed Web of Science ®Google Scholar
• Hue S., Cacoub P., Renou C., et al. Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease. J Infect Dis. 1, 2002; 186(1)106–109
   PubMed Web of Science ®Google Scholar
• Ince N., Wands J.R. The increasing incidence of hepatocellular carcinoma. N. Engl. J. Med. 1999; 340: 798–799
   PubMed Web of Science ®Google Scholar
• Kamel M.A., Miller F.D., EL-Masry A.G. The epidemiology of schistosoma mansoni, hepatitis B and hepatitis C infection in Egypt. Ann. Trop. Med. Parasitol. 1994; 88: 1–9
   Google Scholar
• Kondo Y., Kobayashi K., Kobayashi T., et al. Distribution of the HLA class I allele in chronic hepatitis C and its association with serum ALT level in chronic hepatitis C. Tohoku J. Exp. Med. 2003; 201: 109–117
   PubMed Web of Science ®Google Scholar
• Kuzushita N., Hayashi N., Moribe T., et al. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology 1998; 27: 240
   PubMedGoogle Scholar
• Li P.K., Leung N.W., Poon A.S., et al. Molecular genetics of major histocompatibility complex class II genes in hepatocellular carcinoma. Dig. Dis. Sci. 1995; 40(7)1542–1546
   PubMed Web of Science ®Google Scholar
• Mangia A., Gentile R., Cascavilla I., et al. HLA class II favors clearance of HCV infection and progression of the chronic liver damage. J. Hepatol. 1999; 30: 984–989
   PubMed Web of Science ®Google Scholar
• McKiernan S.M., Hagan R., Curry M., et al. Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 2004; 40(108)
   PubMedGoogle Scholar
• Minton E.J., Smillie D., Neal K.R., et al. Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group. J Infect Dis. 1998; 178: 39–44
   PubMed Web of Science ®Google Scholar
• Montalto G., Cervello M., Giannitrapani L., et al. Epidemiology, risk factors and natural history of hepatocellular carcinoma. Ann. NY Acad. Sci. 2002; 963: 13–20
   PubMed Web of Science ®Google Scholar
• Nelly H.M., Heba M.Z., Nadia M.M., et al. Review of epidemiologic and clinicopathologic features of 403 hepatocellular carcinoma patients. J. Egyptian Nat. Cancer Instit. 2000; 12(2)87–93
   Google Scholar
• Okuda K. Hepatocellular carcinoma. J. Hepatol. 2000; 32: 225–237
   PubMed Web of Science ®Google Scholar
• Par A., Szalay F., Lakatos P.L., et al. Genetic aspects of liver diseases. Orv. Hetil. 6, 2002; 143(1)3–12
   PubMedGoogle Scholar
• Parkhill J., Wren B.W., Mungall K., et al. The genome sequence of the food-borne pathogen campylobacter jejuni reveals hypervariable sequences. Nature 2000; 403: 665–668
   PubMed Web of Science ®Google Scholar
• Pellegris G., Rovagnani F., Notti P., et al. B and C hepatitis viruses, HLA-DQ1 and DR3 alleles and autoimmunity in patients with hepatocellular carcinoma. J. Hepatol. 2002; 36: 521–526
   PubMed Web of Science ®Google Scholar
• Rashmi S., Rashmi K., Anil K., Khalid K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J. Gastroenterol. March 28, 2007; 13(12)1770–1787
   PubMed Web of Science ®Google Scholar
• Shamaa S., El-Bedeway A., Aita M., . Analysis of 192 Egyptian patients with hepatocellular carcinoma. Educational Course on Liver Tumors, S. Omar, N. El-Mawla, H. El-Zawahry, et al. European School of Oncology. 2000; 86–93
   Google Scholar
• Thio C.L., Thomas D.L., Goedert J.J., et al. Racial differences in HLA class II associations with hepatitis C virus outcomes. J. Infect. Dis 1, 2001; 184(1)16–21
   PubMed Web of Science ®Google Scholar
• Thursz M. MHC and the viral hepatitides. QJM 2001; 94: 287–291
   PubMedGoogle Scholar
• Thursz M., Yallop R., Goldin R., et al. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet 1999; 354: 2119–2124
   PubMed Web of Science ®Google Scholar
• Tillman H.L., Chen D.F., Trautwein C., et al. Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease. Gut 2001; 48(5)714–718
   PubMed Web of Science ®Google Scholar
• Vejbaesya S., Songsivilai S., Tanwandee T., et al. HLA association with hepatitis C virus infection. Hum. Immunol. 2000; 61: 348–353
   PubMed Web of Science ®Google Scholar
• Walker B.D., Korber B.T. Immune control of HIV: the obstacles of HLA and viral diversity. Nat. Immunol. 2001; 2: 473
   PubMed Web of Science ®Google Scholar
• Wawrzynowicz-Syczewska M., Underhill J.A., Clare M.A., et al. HLA class II genotypes associated with chronic hepatitis C virus infection and response to alpha-interferon treatment in Poland. Liver 2000; 20: 234–239
   PubMedGoogle Scholar
• Xin H., Rong-Bin Y., Nan-Xiong S., et al. Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: A meta-analysis. World J. Gastroenterol. December 14, 2005; 11(46)7302–7307
   PubMed Web of Science ®Google Scholar
• Yenigun A., Durupinar B. Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection. J. Virol. 2002; 76: 1787–1789
   PubMed Web of Science ®Google Scholar
• Zavaglia C., Martinetti M., Silini E., et al. Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. J. Hepatol. 1998; 28: 1–7
   PubMed Web of Science ®Google Scholar
• Zekri A.R., El-Mahallawy H.A, Hassan A., et al. HLA-alleles in Egyptian HCV genotype-4 carriers. Egyptian J. Immunol. 2005; 12(1)77–86
   PubMedGoogle Scholar